New Year, New Services
Griffin Ferrara2021-01-08T15:14:13-05:00We are excited to finally turn the page on 2020 and get started on 2021 and are looking forward [...]
Imaging Scientist
Mike Johnson2021-01-05T13:19:42-05:00At Visikol, our mission is to accelerate the discovery and development of therapeutics through transforming tissues into quantitative data [...]
High Content Screening for Immune Modulators
Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]
Advances in Immuno-oncology
Over the last decade there has been a boom of companies looking into immunotherapies for treating cancer [...]
Immuno-oncology Therapeutics and Drug Discovery
Immuno-oncology is an exciting field of research that is focused on developing therapeutics the leverage the immune system to [...]
Whole Mount Imaging: Ophthalmologic and Retina Studies
The retina is a vital sheet of nerve tissue at the back of the eye, transforming light signals into [...]
Visikol uses Multiplex Imaging Tools in Partnership with Hackensack Meridian Health
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]
PHH, HepG2 or HepaRG for Drug Induced Liver Injury Studies?
Drug-induced liver injury (DILI) is one of the most frequent causes of safety-related drug marketing withdrawal, according to the [...]
Happy Holidays from Visikol
As we approach the end of 2020, we want to express our gratitude to our partners and customers. We [...]
Happy Thanksgiving from Visikol
While this year we may not be gathering around the table with family and friends, we want to wish [...]